Skip to main content
Premium Trial:

Request an Annual Quote

Steven Gutman

Premium
Steven Gutman, director of the Office of In Vitro Diagnostic Device Safety and Evaluation, will leave the US Food and Drug Administration by the end of the year for a post in academia.
 
Gutman has decided to join the University of Central Florida in January, where he will be a professor of pathology and part of the founding faculty at the university’s new medical school.
 
The FDA has not yet announced who will replace Gutman.
 
In addition to his teaching post at UCF, Gutman said he also hopes to spend time writing and consulting.